- An effective veterinary injectable solution used to control the symptoms of navicular syndrome in horses four years of age and older. It contains clodronate disodium, known for its ability to reduce bone deterioration and improve mobility.
Benefits
- Helps reduce pain and improve quality of movement in injured horses.
- Contributes to the control of clinical symptoms associated with scaphoid bone.
- Effective up to 6 months after the first dose in a large number of cases
- Helps reduce the need to use anti-inflammatories frequently.
How to use
- It is injected intramuscularly at a dose of 1.8 mg per kg of body weight, with a maximum of 900 mg (i.e., 15 ml) per horse.
- The dose is divided into three different injection sites.
- The dose is repeated every 3 to 6 months depending on the horse's condition and body response.
Warnings
- Not for use in horses intended for human consumption.
- Do not use concomitantly with NSAIDs to avoid kidney toxicity.
- Contraindicated in horses with kidney problems or mineral imbalances.
- Its safety has not been tested in pregnant or lactating horses or horses under 4 years of age.
Get Osphos now to treat the navicular bone and improve your horse's performance from the first dose.